2003

Mar 30, 2003
Guidant Reports Positive Six-Month Clinical Results of Everolimus Eluting Coronary Stent

Data Supports Use of Everolimus for Drug Eluting Stents Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...

Mar 30, 2003
Guidant Announces Preliminary 30-Day Results of Study of Carotid Artery Stenting as Alternative Treatment for High Surgical-Risk Patients

Study Evaluates Potential New Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...

Mar 28, 2003
Guidant Reports Results of Preclinical Study of Stents for Treatment of Vulnerable Plaque

Study Evaluates Therapeutic Options for Preventing Heart Attacks Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Mar 19, 2003
Guidant Signs Definitive Agreement to Acquire Biosensors' Everolimus Eluting Stent Assets

Company Updates Status of Drug Eluting Stent Program Webcast/Conference Call Scheduled for Thursday, March 20, at 11:00 AM ET Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader...

Mar 19, 2003
Guidant to Host Investor Briefing at American College of Cardiology Meeting

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...

Mar 13, 2003
Guidant Announces First Implant in New Heart Failure Scientific Study

U.S. Study Continues Guidant''s Leadership in Clinical Science St. Paul, Minn. and Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Mar 12, 2003
Guidant Launches Fifth-Generation System in Japan

MULTI-LINK PENTA Stent System Brings Guidant''s Outstanding Stent Design Technology to Japanese Physicians and Patients Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT), a world...

Mar 11, 2003
Guidant Acquires Innovative Interventional Technology

FX miniRAIL Coronary Device Aims to Expand Physicians'' Options In the Treatment of De Novo Lesions and In-Stent Restenosis Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...

Mar 11, 2003
Guidant Appoints Dana G. Mead, Jr. President, Vascular Intervention

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Dana G. Mead, Jr., currently vice president, Corporate...

Feb 25, 2003
Guidant to Participate in the Lehman Brothers Global Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...

Feb 18, 2003
Guidant Announces Quarterly Dividend

Company Sets Date for Annual Meeting of Shareholders Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...

Feb 17, 2003
Guidant Announces U.S. Market Launch of the Newest Addition to its Pacemaker Portfolio

INSIGNIA Entra is Small, Smart and Long-Lasting Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Feb 14, 2003
Guidant to Host Mid-Quarter Update Today at 11:00 a.m. EST

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a conference call to provide an...

Feb 12, 2003
Guidant Applauds Recommendation for Nationwide Medicare Coverage for Defibrillator Implants

Medicare Coverage Advisory Committee Recommends Expanding Coverage to Include MADIT II Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Feb 4, 2003
Guidant Provides Summary of Evidence for Medicare Coverage Advisory Committee on ICD Therapy

Background Materials Available for Review Online Indianapolis, Ind. - Guidant today announced that background materials from Guidant have been provided to the Centers for Medicare and Medicaid...

Feb 3, 2003
Ron Lattanze Promoted to Guidant Management Committee as President of Guidant's Japan Operations

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ron Lattanze, president, Guidant Japan, has been...

Feb 3, 2003
Guidant Appoints Maria Degois-Sainz President, Cardiac Surgery

Degois-Sainz Joins Guidant Management Committee Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that...

Feb 3, 2003
Guidant Appoints Nicky Spaulding President of European Operations

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding currently president, Cardiac Surgery, Guidant, has been named president, Guidant Europe, Middle...

Jan 31, 2003
Guidant to Participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

Jan 30, 2003
Guidant Reports All-Time Record Fourth Quarter and Full-Year 2002 Sales and Adjusted Earnings

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...

Jan 24, 2003
Guidant Commends New European Guideline for Defibrillator Implants

Enhanced Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Jan 22, 2003
Long-Term Follow-Up Clinical Data on Guidant's ANCURE Bifurcated System Demonstrates Continued Durability at Five Years

More Than 97 Percent of Patients Studied Experienced Stable or Shrinking Aneurysm Size Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jan 21, 2003
Guidant to Participate in U.S. Bancorp Piper Jaffray Health Care Conference

Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the treatment of cardiac and vascular disease, today announced that it...

Jan 17, 2003
Guidant Announces Live Webcast of its Fourth Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its fourth quarter 2002 earnings...

Jan 16, 2003
Guidant Announces European CE Mark and First Implant of Next-Generation Implantable Defibrillator

VITALITY AVT Offers Complete Ventricular and Atrial Therapy Options Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Show per page

Top